Pharmacy Times

JUNE 18, 2025

Mok : Right now, we have a lot of chemotherapy being used, but there are many more novel treatments being studied, especially in earlier lines of treatment. Bispecifics are moving up in the lymphoma space, and these newer therapies may have some synergistic effects with chemotherapy. REFERENCES 1. Updated August 18, 2021.

Chemotherapy

Pharmacy Times

AUGUST 7, 2025

Methods Patients aged 18 to 59 years with t-AML or AML-MRC treated with CPX-351 or 7+3 as induction chemotherapy between 2015 and 2022 at 3 National Cancer Institute–designated cancer centers were included. The primary outcome was the incidence of CR or CRi after induction chemotherapy. Author Disclosures Brian A.

Chemotherapy

Pharmacy Times

JULY 3, 2025

I think it’ll be chemotherapy—maybe their cells being given outpatient—and then, as we hit their hardest time or their highest risk for either febrile neutropenia or mucositis or even some of the toxicities from the chemotherapy, we have them inpatient until we feel comfortable, and then transition it so that it could be all outpatient.

Specialty Pharmacies

Pharmaceutical Technology

JULY 1, 2025

In June 2025, the European Commission authorised Takeda’s Adcetris (brentuximab vedotin), an antibody-drug conjugate, combined with chemotherapy for treating adults who are newly diagnosed with Stage IIb Hodgkin’s lymphoma with risk factors or at Stage III/IV. Sign up for our daily news round-up!

FDA

Pharmaceutical Technology

JULY 4, 2025

Go deeper with GlobalData Reports LOA and PTSR Model - Denosumab Biosimilar in Bone Metastasis Reports LOA and PTSR Model - Denosumab Biosimilar in Chemotherapy Effects Data Insights The gold standard of business intelligence. Find out more Sign up for our daily news round-up! Give your business an edge with our leading industry insights.

Chemotherapy

Pharmaceutical Technology

JULY 7, 2025

Find out more J&J’s drug is an option for patients where medical or surgical treatment to lower testosterone levels has not worked, and in those who have BRCA 1/2 mutations – a subset of homologous recombination repair (HRR) mutations – in whom chemotherapy is not indicated. Give your business an edge with our leading industry insights.

Labelling

Pharmaceutical Technology

JULY 4, 2025

Imfinzi is now approved to treat adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with chemotherapy drugs gemcitabine and cisplatin as neoadjuvant treatment, and as a monotherapy after bladder removal surgery. Imfinzi is a major revenue driver for AstraZeneca, generating around $4.7bn in sales in 2024.

Chemotherapy

Pharmaceutical Technology

JULY 3, 2025

Dizal has received US Food and Drug Administration (FDA) approval for Zegfrovy (sunvozertinib) to treat adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations (exon20ins), following progression on or after receiving platinum-based chemotherapy.

FDA

Pharmafile

MARCH 3, 2023

Scientists from the Institute of Cancer Research London, Imperial College London and the Netherlands Cancer Institute have researched a gene test which can select which advanced bowel cancer patients will respond the best to chemotherapy. read more

Chemotherapy

Pharmafile

APRIL 25, 2023

GSK has announced that the European Medicines Agency (EMA) has validated the company’s Type II Variation for a new indication for Jemperli (dostarlimab) alongside chemotherapy for the treatment of adult patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer.

Chemotherapy

pharmaphorum

MAY 10, 2022

Results of the pilot in 45 patients with non-small cell lung cancer (NSCLC) treated with Tecentriq with and without chemotherapy were published in 2020. The data showed that patients as well as physicians and nursing staff found the digital tool allowed “more efficient and focused communication” as well as time savings.

Chemotherapy

Pharmafile

APRIL 5, 2023

AstraZeneca has announced positive high-level results from an interim analysis of the DUO-O phase 3 trial assessing a combination of Lynparza (olaparib) and Imfinzi (durvalumab) alongside chemotherapy and bevacizumab. read more

Chemotherapy

Pharmaceutical Technology

JANUARY 17, 2023

It could be used for T-Cell Acute Lymphoblastic Leukaemia (T-ALL) treatment in patients for whom bone marrow transplantation and chemotherapy failed to work. The Spanish Association Against Cancer (AECC) provided funding for the new STAb therapy development.

Hospitals

Pharmafile

NOVEMBER 25, 2022

Clinical evidence shows Bristol Myers Squibb’s nivolumab, with chemotherapy, could help extend the lives of patients with untreated HER2-negative, advanced or metastatic gastric, gastroesophageal junction, or oesophageal adenocarcinoma, if the tumours express PD-L1. read more.

Chemotherapy

European Pharmaceutical Review

JULY 4, 2023

Since the first ADC was approved by the EMA in 2012, they have generated a great deal of interest in the oncology field because of their potential to address many of the challenges of traditional chemotherapy options. Teams must also accept the variety of analytical procedures these regulatory agencies prefer.

Communication

Hospital Pharmacy Europe

DECEMBER 18, 2023

4,5 Polypharmacy – daily use of five or more drugs – is common in these patients and increases the risk of DRPs, which can result in adverse outcomes such as postoperative complications, chemotherapy toxicities and functional decline. 10,11 This can be due to side effects of chemotherapy or the addition of certain supportive care medications.

Chemotherapy

Pharmafile

MARCH 20, 2023

AstraZeneca and MSD have announced that the MHRA has granted marketing authorisation for Lynparza (olaparib) in the UK, when used in combination with abiraterone and prednisone or prednisolone, to treat metastatic castration-resistant prostate cancer (mCRPC) in patients for whom chemotherapy is not recommended. read more

Chemotherapy

The Checkup by Singlecare

AUGUST 15, 2024

The most common reasons ondansetron is needed in cats are chemotherapy, drug treatment, and pancreatitis (inflamed pancreas). Communication between the brain’s nausea center and the gastrointestinal tract is blocked, so the brain can’t activate the vomiting reflex. As in humans, doses may be given both before and after chemotherapy.

Dosage

Pharmafile

JANUARY 27, 2023

The antibody treatment was previously used as an additional layer of protection against the virus for those with compromised immune systems, such as those undergoing chemotherapy, or organ-transplant patients. read more

FDA

The Checkup by Singlecare

NOVEMBER 28, 2023

Causes of neuropathy can also include autoimmune diseases like rheumatoid arthritis, nutrient deficiencies, medication toxicity (such as chemotherapy), genetics, and age-related changes, says Dr. Machemehl. Multiple sclerosis is a nervous system disorder that often causes toe numbness.

Chemotherapy

Hospital Pharmacy Europe

JULY 27, 2023

Published in the journal Nature Communications , the researchers conducted a Phase I dose escalation trial , with the primary objective of exploring the safety and tolerability of the MOv18 IgE antibody. The results pave the way to development of an entirely new class of anti-cancer drug for people with chemotherapy-resistant cancers.

Chemotherapy

BuzzRx

SEPTEMBER 2, 2022

Losing hearing permanently can have a profound impact on a person’s ability to communicate and, consequently, on their personal, professional, and social life. Chemotherapy Drugs Chemo drugs like cisplatin and carboplatin are used to kill cancer cells. Hearing loss is extremely common and affects approximately 30 million Americans.

Chemotherapy

The Checkup by Singlecare

NOVEMBER 21, 2024

It is important to communicate all of your symptoms and a timeline of when they started with your healthcare provider, who will determine the best course of treatment. Exceptions include people who have a compromised immune system, are taking steroids, or are in chemotherapy. It can be caused by bacteria or by a virus.

Dosage

PharmaShots

MAY 19, 2023

This type of hearing loss can cause significant communication problems, particularly in noisy environments, and can affect an individual's personal and professional life. Medications: Some medications, such as antibiotics and chemotherapy drugs, can cause hearing loss as a side effect.

Communication

pharmaphorum

SEPTEMBER 4, 2020

Traditionally, cancer patients are treated using “one size fits all” interventions like chemotherapy, radiotherapy and surgery. Visual communication. These tools not only make it easier to understand the service, but they can also help simplify communication and increase alignment between the many individuals engaged in the project.

Communication

Pharmaceutical Technology

SEPTEMBER 23, 2022

The current standard of care for many cancers is cisplatin chemotherapy or platinum therapy. Additionally , loss of hearing at a young age is associated with impaired communication, cognitive impairment, poorer mental health and quality of life. The therapeutic landscape.

FDA

Pharmaceutical Technology

JUNE 16, 2023

Designated as BG01-2202, this latest trial will be an open-label, randomised, controlled clinical study of UTD1 versus chemotherapy drug docetaxel. A Phase III study to evaluate UTD1 versus docetaxel in patients that have failed chemotherapy with a platinum-containing regimen is also currently underway in China. ORR, 81.0%

FDA

Pharmaceutical Technology

FEBRUARY 17, 2023

They state that newer drugs like monoclonal antibodies and kinase inhibitors may benefit from a drug optimisation approach due to their different dose escalation profiles, compared to the cytotoxic chemotherapy drugs. Please check your email to download the Report.

Dosage

Viseven

OCTOBER 31, 2023

The journey that followed—filled with the courses of chemotherapy, surgeries, and radiation—tested me in ways I could never have imagined. The company’s mission to save lives by improving communication has become Nataliya’s personal guiding principle. Yet, throughout this tumultuous journey, I never once contemplated giving up.

Chemotherapy

Pharmaceutical Technology

MAY 31, 2023

Chemotherapy used to treat blood cancer results in increased intestinal permeability, making E. Subjects were dosed over seven days, and reportedly only experienced mild to moderate side effects with no withdrawals. coli a frequent cause of bloodstream infections that carries a 15-20% fatality rate.

Chemotherapy

Pharmaceutical Technology

JUNE 16, 2023

In 2021, as part of the same Keynote-811 trial, the US Food and Drug Administration (FDA) granted accelerated approval to Keytruda for treating locally advanced unresectable or metastatic HER2-positive gastric or GEJ adenocarcinoma, in combination with trastuzumab and chemotherapy containing fluoropyrimidin and platinum.

Chemotherapy

Pharmaceutical Technology

JUNE 5, 2023

In results presented at the ongoing American Society of Clinical Oncology (ASCO) Annual Meeting , Summit reported an overall response rate (ORR) of 67% in NSCLC patients with squamous histology treated with its lead drug ivonescimab plus chemotherapy. The treatment had an acceptable safety profile in combination with chemotherapy.

Chemotherapy

BuzzRx

JANUARY 11, 2023

Recent research has shown that the gut microbiome influences interactions in the gut-brain axis (bidirectional communication between your gut and brain). This includes people with compromised immune systems (following chemotherapy , for example) and those who have had a recent critical illness or surgery. References: [link].

Immunization

The Checkup by Singlecare

JANUARY 23, 2024

It is known as an antineoplastic (chemotherapy) agent, a disease-modifying antirheumatic drug ( DMARD ), and an immunosuppressant agent. Methotrexate has distinct mechanisms of action for its use as chemotherapy versus immunosuppression in autoimmune diseases.

Adverse Reactions

The Checkup by Singlecare

OCTOBER 16, 2023

Chemotherapy-Induced Peripheral Neuropathy Studies have shown that duloxetine may help prevent or reduce nerve pain in people who have been treated with chemotherapy. Communicate any concerns or questions about the switch to your healthcare provider, as they can offer personalized advice based on your medical history and overall needs.

Dosage

pharmaphorum

MARCH 9, 2021

Now, people living with particular types of lymphoma have individualised options beyond chemotherapy for the first time.”. We’ve learnt how best to communicate with people, their care partners and families, so they’re fully informed and able to take part in the conversation.

Chemotherapy

Pharmaceutical Technology

APRIL 12, 2023

The company is focused on its planned first-in-human trial designed for assessing DNase, along with immune checkpoint inhibitors or chemotherapy. The collaboration will also support the development of XCART, a DNase-armoured personalised chimeric antigen receptor (CAR) T cell technology for the treatment of B-Cell lymphomas.

Chemotherapy